IL147920A0 - Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants - Google Patents
Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plantsInfo
- Publication number
- IL147920A0 IL147920A0 IL14792000A IL14792000A IL147920A0 IL 147920 A0 IL147920 A0 IL 147920A0 IL 14792000 A IL14792000 A IL 14792000A IL 14792000 A IL14792000 A IL 14792000A IL 147920 A0 IL147920 A0 IL 147920A0
- Authority
- IL
- Israel
- Prior art keywords
- cgmmv
- resistant plants
- generating
- genetic constructs
- plants
- Prior art date
Links
- 230000002068 genetic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/127—RNA-directed RNA polymerase (2.7.7.48), i.e. RNA replicase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99202540 | 1999-08-02 | ||
| PCT/NL2000/000534 WO2001009300A2 (en) | 1999-08-02 | 2000-07-27 | Method for generating cgmmv resistant plants, genetic constructs, and obtained cgmmv-resistant plants |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL147920A0 true IL147920A0 (en) | 2002-08-14 |
Family
ID=8240518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL14792000A IL147920A0 (en) | 1999-08-02 | 2000-07-27 | Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1198572A2 (en) |
| AU (1) | AU6322900A (en) |
| IL (1) | IL147920A0 (en) |
| WO (1) | WO2001009300A2 (en) |
Families Citing this family (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1358341B1 (en) * | 2001-02-08 | 2011-05-25 | Keygene N.V. | Methods for generating resistance against cgmmv in plants |
| US8393001B1 (en) | 2002-07-26 | 2013-03-05 | Mcafee, Inc. | Secure signature server system and associated method |
| US20040266806A1 (en) | 2003-04-08 | 2004-12-30 | Sanghvi Suketu P. | Pharmaceutical formulation |
| ZA200607843B (en) * | 2004-02-23 | 2008-06-25 | Israel State | Engrafted plants resistant to viral diseases and methods of producing same |
| EP1844073A1 (en) | 2005-01-31 | 2007-10-17 | Ablynx N.V. | Method for generating variable domain sequences of heavy chain antibodies |
| LT2949668T (en) | 2005-05-18 | 2019-11-11 | Ablynx Nv | Improved nanobodies tm against tumor necrosis factor-alpha |
| TR201815552T4 (en) | 2005-05-20 | 2018-11-21 | Ablynx Nv | Improved nanoantibodies (TM) for the treatment of aggregation-related diseases. |
| TWI489984B (en) | 2006-08-04 | 2015-07-01 | Wyeth Corp | Formulations for parenteral delivery of compounds and uses thereof |
| AU2007336242B2 (en) | 2006-12-19 | 2012-08-30 | Ablynx N.V. | Amino acid sequences directed against GPCRs and polypeptides comprising the same for the treatment of GPCR-related diseases and disorders |
| CA2672965C (en) | 2006-12-19 | 2018-02-06 | Ablynx N.V. | Amino acid sequences directed against a metalloproteinase from the adam family and polypeptides comprising the same for the treatment of adam-related diseases and disorders |
| JP5266489B2 (en) * | 2007-03-14 | 2013-08-21 | 国立大学法人愛媛大学 | Gene silencing suppression technology |
| CA2865389A1 (en) | 2007-03-29 | 2008-10-09 | Progenics Pharmaceuticals, Inc. | Crystal forms and uses thereof |
| JP2011504740A (en) | 2007-11-27 | 2011-02-17 | アブリンクス エン．ヴェー． | Amino acid sequence directed to heterodimeric cytokines and / or their receptors, and polypeptides containing the same |
| US8766041B2 (en) | 2008-01-10 | 2014-07-01 | Enza Zaden Beheer B.V. | Marker genetically linked to tobamovirus resistance in cucumber and the use thereof |
| WO2009099411A1 (en) | 2008-02-06 | 2009-08-13 | Progenics Pharmaceuticals, Inc. | Preparation and use of (r),(r)-2,2'-bis-methylnaltrexone |
| AU2009221106A1 (en) | 2008-03-05 | 2009-09-11 | Ablynx Nv | Novel antigen binding dimer-complexes, methods of making and uses thereof |
| CN102056945A (en) | 2008-04-07 | 2011-05-11 | 埃博灵克斯股份有限公司 | Amino acid sequences directed against the Notch pathways and uses thereof |
| JP2011516603A (en) | 2008-04-17 | 2011-05-26 | アブリンクス エン．ヴェー． | Peptides capable of binding to serum proteins and compounds, constructs and polypeptides containing them |
| EP2403873A1 (en) | 2009-03-05 | 2012-01-11 | Ablynx N.V. | Novel antigen binding dimer-complexes, methods of making/avoiding and uses thereof |
| JP5647222B2 (en) | 2009-04-10 | 2014-12-24 | アブリンクス エン．ヴェー． | Improved amino acid sequence directed against IL-6R for the treatment of IL-6R related diseases and disorders and polypeptides comprising the same |
| SG176095A1 (en) | 2009-06-05 | 2011-12-29 | Ablynx Nv | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| WO2011040978A2 (en) | 2009-10-02 | 2011-04-07 | Ludwig Institute For Cancer Research Ltd. | Immunodominant mhc dr52b restricted ny-eso-1 epitopes, mhc class ii monomers and multimers, and uses thereof |
| US9644022B2 (en) | 2009-11-30 | 2017-05-09 | Ablynx N.V. | Amino acid sequences directed against human respiratory syncytial virus (HRSV) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections |
| JP2013518853A (en) | 2010-02-05 | 2013-05-23 | アブリンクス エン．ヴェー． | Peptides capable of binding to serum albumin and compounds, constructs and polypeptides containing the same |
| EA202092589A3 (en) | 2010-11-08 | 2021-06-30 | Аблинкс Н.В. | CXCR2-BINDING POLYPEPTIDES |
| AU2012273928A1 (en) | 2011-06-23 | 2014-02-06 | Ablynx Nv | Immunoglobulin single variable domains directed against IgE |
| US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
| WO2014087010A1 (en) | 2012-12-07 | 2014-06-12 | Ablynx N.V. | IMPROVED POLYPEPTIDES DIRECTED AGAINST IgE |
| NL1040254C2 (en) | 2013-05-17 | 2014-11-24 | Ablynx Nv | Stable formulations of immunoglobulin single variable domains and uses thereof. |
| NL2013007B1 (en) | 2014-06-16 | 2016-07-05 | Ablynx Nv | Methods of treating TTP with immunoglobulin single variable domains and uses thereof. |
| NL2013661B1 (en) | 2014-10-21 | 2016-10-05 | Ablynx Nv | KV1.3 Binding immunoglobulins. |
| JP6743051B2 (en) | 2015-01-27 | 2020-08-19 | ラヴァ・セラピューティクス・ベー・フェー | Single domain antibody targeting CD1D |
| PE20181956A1 (en) | 2015-11-27 | 2018-12-17 | Ablynx Nv | POLYPEPTIDES THAT INHIBIT CD40L |
| US11098113B2 (en) | 2016-09-15 | 2021-08-24 | Vib Vzw | Immunoglobulin single variable domains directed against macrophage migration inhibitory factor |
| JP7222888B2 (en) | 2016-11-16 | 2023-02-15 | アブリンクス エン．ヴェー． | T cell engaging polypeptides capable of binding CD123 and TCR alpha/beta |
| JP2020521804A (en) | 2017-06-02 | 2020-07-27 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ | MMP13 binding immunoglobulin |
| JP7249961B2 (en) | 2017-06-02 | 2023-03-31 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング | Polypeptides that bind ADAMTS5, MMP13 and aggrecan |
| HRP20241562T1 (en) | 2017-06-02 | 2025-01-31 | Merck Patent Gmbh | Adamts binding immunoglobulins |
| SG10202113337YA (en) | 2017-06-02 | 2021-12-30 | Ablynx Nv | Aggrecan binding immunoglobulins |
| CN107860774B (en) * | 2017-11-10 | 2020-01-07 | 青岛市农业科学研究院 | A screening method for sensitive genotypes of Agrobacterium tumefaciens in cucumber |
| CN111670202A (en) | 2018-02-06 | 2020-09-15 | 埃博灵克斯股份有限公司 | Methods of treating initial episodes of TTP with immunoglobulin single variable domains |
| JP7603600B2 (en) | 2019-03-08 | 2024-12-20 | リンクシス ベスローテン フェンノートシャップ | Internalizing binding molecules that target receptors involved in cell proliferation or cell differentiation |
| WO2020245663A1 (en) | 2019-06-01 | 2020-12-10 | Institut Pasteur | Nanobody-based ns1 assay for the specific diagnosis of acute zika virus infection |
| EP4214235A1 (en) | 2020-09-16 | 2023-07-26 | LinXis B.V. | Internalizing binding molecules |
| EP4019548A1 (en) | 2020-12-23 | 2022-06-29 | Vrije Universiteit Brussel | Anti lag3 vhhs and their use |
| CN112920262B (en) * | 2021-02-03 | 2022-09-16 | 浙江省农业科学院 | Protein ClALKBH2B capable of inhibiting CGMMV accumulation, gene, expression vector, transformant and method thereof |
| CN115433733B (en) | 2021-06-04 | 2025-12-12 | 生物岛实验室 | Polypeptides translated from circular RNA Circ-ACE2 and their applications |
| EP4419561A2 (en) | 2021-10-20 | 2024-08-28 | Takeda Pharmaceutical Company Limited | Compositions targeting bcma and methods of use thereof |
| CN114107371B (en) * | 2021-12-06 | 2024-03-29 | 中国农业科学院郑州果树研究所 | Cucumber green mottle mosaic virus gene mediated transgenic tobacco method |
| CN116837004A (en) * | 2021-12-06 | 2023-10-03 | 中国农业科学院郑州果树研究所 | Chimeric structure IMC and its application in cultivating cucumber green mottle mosaic virus-resistant tobacco |
| CN117402243A (en) | 2022-07-14 | 2024-01-16 | 百奥泰生物制药股份有限公司 | Anti-Nectin-4 antibodies and their applications |
| IL318486A (en) | 2022-07-27 | 2025-03-01 | Ablynx Nv | Polypeptides binding to a specific epitope of the neonatal fc receptor |
| US20240415974A1 (en) | 2022-12-23 | 2024-12-19 | Ablynx N.V. | Protein-based conjugation carriers |
| CN116218807B (en) * | 2022-12-30 | 2025-08-26 | 河南农业大学 | Protein interacting with cucumber green mottle mosaic virus MP protein, its encoding gene, and application |
| AU2024221136A1 (en) | 2023-02-17 | 2025-10-02 | Ablynx N.V. | Polypeptides binding to the neonatal fc receptor |
| WO2024261235A1 (en) | 2023-06-22 | 2024-12-26 | Ablynx Nv | Chimeric proteins for modulating cytokine receptor activity |
| US20250034260A1 (en) | 2023-07-05 | 2025-01-30 | Sanofi | Fcrn antagonists for treatment of igg-related diseases and disorders |
| AR133725A1 (en) | 2023-09-04 | 2025-10-29 | Sanofi Sa | POLYPEPTIDES FOR USE IN THE TREATMENT OF GLYPICAN-3 EXPRESSING TUMORS |
| AR133903A1 (en) | 2023-09-22 | 2025-11-12 | Ablynx Nv | BI- AND MULTIVALENT ALBUMIN BINDING AGENTS |
| TW202542180A (en) | 2023-12-22 | 2025-11-01 | 比利時商艾伯霖克斯公司 | Protein-based carriers for site-specific amine conjugation |
| TW202543670A (en) | 2023-12-22 | 2025-11-16 | 比利時商艾伯霖克斯公司 | Protein-based conjugation carriers for intranuclear delivery |
| WO2025207946A1 (en) | 2024-03-28 | 2025-10-02 | Genzyme Corporation | Polypeptides binding to a specific epitope of the transferrin receptor 1 |
| US20260007757A1 (en) | 2024-06-18 | 2026-01-08 | Ablynx Nv | Antibody-recruiting molecules |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1991013542A1 (en) * | 1990-03-12 | 1991-09-19 | Cornell Research Foundation, Inc. | Transformation of plants with non-structural plant virus gene sequences |
| GB9208545D0 (en) * | 1992-04-21 | 1992-06-03 | Gatsby Charitable Foundation T | Virus resistant plants |
-
2000
- 2000-07-27 EP EP00950079A patent/EP1198572A2/en not_active Withdrawn
- 2000-07-27 AU AU63229/00A patent/AU6322900A/en not_active Abandoned
- 2000-07-27 WO PCT/NL2000/000534 patent/WO2001009300A2/en not_active Ceased
- 2000-07-27 IL IL14792000A patent/IL147920A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1198572A2 (en) | 2002-04-24 |
| WO2001009300A3 (en) | 2001-08-23 |
| WO2001009300A2 (en) | 2001-02-08 |
| AU6322900A (en) | 2001-02-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL147920A0 (en) | Method for generating cgmmv resistant plants, genetic constructs, and the obtained cgmmv-resistant plants | |
| PT2944695T (en) | Novel plant expression constructs | |
| PL345829A1 (en) | Plants which synthesize a modified starch, methods for producing the plants, their use, and the modified starch | |
| ZA200202843B (en) | Method for improving growth. | |
| HUP0104914A3 (en) | Galenicformulations fast disintegrating the mouth and method for preparing same | |
| IL145686A0 (en) | Plant transformation method | |
| GB9921337D0 (en) | Modified plant viruses | |
| MX9911116A (en) | Plant transformation methods | |
| MXPA02003232A (en) | Compositions and methods for altering gene expression. | |
| ZA200109348B (en) | Noninvasive genetic immunization, expression products therefrom, and uses thereof. | |
| ZA994522B (en) | Coating plant. | |
| ZA9711103B (en) | Plant support. | |
| HUP0200144A3 (en) | Process for preparing pesticidal 5-amino-1-aryl-3 cyanopyrazole derivatives, and the new intermediates | |
| EP1144608A3 (en) | Synthetic vectors, transgenic plants containing them, and methods for obtaining them | |
| GB9920816D0 (en) | Plant gene | |
| ZA200002546B (en) | Sorbate-preserved compositions, method for the manufacture thereof and their use. | |
| GB0029720D0 (en) | I.S machine7544232001 | |
| IL146573A0 (en) | Method for producing 2,2,4,4-tetra-substituted 1,3,5-cyclohexanetriones | |
| AP2003002872A0 (en) | Plant invigorator. | |
| EP1206524A4 (en) | Methods for generating doubled haploid plants | |
| GB9917109D0 (en) | Plant genes | |
| GB9923100D0 (en) | Improved plant | |
| ZA200109201B (en) | Expression of sedoheptulose 1,7 bisphosphatase in transgenic plants. | |
| GB9928605D0 (en) | Rein | |
| ZA200002057B (en) | Process for preparing 8-cyclopentyl-6-ethyl-3-(substituted)-5,8-dihydro-4H-1,2,3A,7,8-pentaaza-as-indacenes and intermediates useful therein. |